APOE in non-Alzheimer amyloidoses: Transmissible spongiform encephalopathies

Neurology

Volumn 51, Issue 2, 1998, Pages 548-553

  Chapman, J ^c   Cervenakova L ^b   Petersen, R B ^d   Lee, H S ^a   Estupinan, J ^a   Richardson, S ^d   Vnencak Jones, C L ^e   Gajdusek, D C ^b   Korezyn, A D ^c   Brown, P ^b   Goldfarb, Lev G ^a,b  

^a Unit of Gene Mapping and Expression   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; AMYLOIDOSIS; ARTICLE; CREUTZFELDT JAKOB DISEASE; DISEASE PREDISPOSITION; FATAL FAMILIAL INSOMNIA; GENOTYPE; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; KURU; MAJOR CLINICAL STUDY; POINT MUTATION; PRION DISEASE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0344505834     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.2.548     Document Type: Article

References (41)

1. Saunders AM, Schmader K, Breitner JC, et al. Apolipoprotein E ∈4 allele distribution in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342:710-711.
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
3. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
4. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci 1996;19:53-77.
5. Blacker D, Haines JL, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH Genetics Initiative. Neurology 1997;48:139-147.
6. Shimada K, Yasuda M, Maeda K. Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease. Seishin Shinkeigaku Zasshi 1997;99:575-587.
7. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interaction. Neuron 1993;11:575-580.
8. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-238.
9. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163-166.
10. Bugiani O, Giaccone G, Frigerio L, et al. Apolipoprotein E and J immunoreactivity in Gerstmann-Sträussler-Scheinker disease. Neurobiol Aging 1994;15:156-157.
11. Goldfarb LG, Brown P. The transmissible spongiform encephalopathies. Annu Rev Med 1995;46:57-65.
12. Amouyel P, Vidai O, Launay JM, Laplanche JL. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 1994;344:1315-1318.
13. Nakagawa Y, Kitamoto T, Furukawa H, Ogomori K, Tateishi J. Apolipoprotein E in Creutzfeldt-Jakob disease. Lancet 1995;345:68. Letter.
14. Zerr I, Helmhold M, Weber T. Apolipoprotein E in Creutzfeldt-Jakob disease [letter]. Lancet 1995;345:68-69.
15. Salvatore M, Seeber AC, Nacmias B, et al. Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease. Neurosci Lett 1995;199:95-98.
16. Friedman J, Gabizon R, Shapira A, et al. Association of apolipoprotein E4 alleles with Alzheimer's disease but not with Down syndrome or Creutzfeldt-Jakob disease. Alzheimer Res 1995;1:45-48.
17. Zerr I, Helmhold M, Poser S, Armstrong VW, Weber T. Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease. Arch Neurol 1996;53:1233-1238.
18. Pickering-Brown SM, Mann DM, et al. Allelic variations in apolipoprotein E and prion protein genotype related to plaque formation and age of onset in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 1995;187:127-129.
19. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-529.
20. Lys mutation: an analysis of 45 families. Eur J Epidemiol 1991;7:477-486.
21. Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdsek DC. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 1990;336:637. Letter.
22. Asn PRNP mutation in families of European origin. Ann Neurol 1992;31:274-281.
23. Goldfarb LG, Brown P, McCombie WR, et al. Transmissible familial Creutzfeldt-Jakob disease is associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci USA 1991;88:10926-10930.
24. Petersen RB, Tabaton M, Berg L, et al. Analysis of the prion protein gene in thalamic dementia. Neurology 1992;42:1859-1863.
25. Medori R, Tritschler H-J, LeBlanc A, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992;326:444-449.
26. Brown P, Goldfarb LG, Brown WT, et al. Clinical and molecular genetic study of a large German kindred with Gerstmann-Sträussler-Scheinker syndrome. Neurology 1991;41:375-379.
27. Gajdusek DC, Zigas V. Kuru: clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the Eastern Highlands of New Guinea. Am J Med 1959;26:442-469.
28. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159. Letter.
29. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31:545-548.
30. Chapman J, Estupinan J, Asherov A, Goldfarb LG. A simple and efficient method for apolipoprotein E genotype determination. Neurology 1996;46:1484-1485.
31. Wilson PFW, Myers RH, Larson MG, et al. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. JAMA 1994; 272:1666-1671.
32. Corbo RM, Scacchi R, Mureddu L, et al. Apolipoprotein E polymorphism in Italy investigated in native plasma by a simple polyacrylamide gel isoelectric focusing technique: comparison with frequency data of other European populations. Ann Hum Genet 1995;59:197-209.
33. Haltia M, Viitanen M, Sulkava R et al. Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol 1994;36:362-367.
34. Roses AD, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E in Creutzfeldt-Jakob disease. Lancet 1995;345:369. Letter.
35. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437.
36. Lys mutation: analysis of 45 families. Eur J Epidemiol 1991;7:477-486.
37. Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD. The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 1994;44: 1683-1686.
38. Spudich S, Mastrianni JA, Wrensch M, et al. Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med 1995; 1:607-613.
39. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37:254-259.
40. de Knijff P, Johansen LG, Rosseneu M, et al. Lipoprotein profile of a Greenland Inuit population: influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle. Arterioscler Thromb 1992;12:1371-1379.
41. Betard C, Robitaille Y, Gee M, et al. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, and Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport 1994;5:1893-1896.